FDG PET/CT in the management of colorectal and anal cancers.

Journal Article (Journal Article;Review)

OBJECTIVE: CT remains the imaging modality of choice in the diagnosis of colorectal cancer (CRC) and anal cancer. However, advances in imaging have expanded the role of MRI and PET/CT. This article focuses on the evolving role of FDG PET/CT in the diagnosis, radiation therapy planning, therapy assessment, and posttherapy monitoring of CRC and anal cancer. CONCLUSION: FDG PET/CT is a valuable imaging modality that impacts the clinical management of patients with CRC and those with anal cancer.

Full Text

Duke Authors

Cited Authors

  • Agarwal, A; Marcus, C; Xiao, J; Nene, P; Kachnic, LA; Subramaniam, RM

Published Date

  • November 2014

Published In

Volume / Issue

  • 203 / 5

Start / End Page

  • 1109 - 1119

PubMed ID

  • 25341152

Electronic International Standard Serial Number (EISSN)

  • 1546-3141

Digital Object Identifier (DOI)

  • 10.2214/AJR.13.12256


  • eng

Conference Location

  • United States